Skip to main content
Future Journal of Pharmaceutical Sciences

Table 8 Analysis of marketed formulation of evogliptin tartrate

From: Box–Behnken design-assisted optimization of RP-HPLC method for the estimation of evogliptin tartrate by analytical quality by design

Name of marketed formulation

Label claim (mg)

Amount recovered* ± SD

% Assay* ± SD

Valera

5

4.98 ± 0.10

99.81 ± 1.36

  1. *Average of six determinant
Back to article page